AstraZeneca PLC (LON:0A4J)
London flag London · Delayed Price · Currency is GBP · Price in USD
82.89
-1.66 (-1.97%)
At close: Oct 29, 2025

AstraZeneca Revenue

AstraZeneca had revenue of $15.19B USD in the quarter ending September 30, 2025, with 11.99% growth. This brings the company's revenue in the last twelve months to $58.13B, up 13.52% year-over-year. In the year 2024, AstraZeneca had annual revenue of $54.07B with 18.03% growth.

Revenue (ttm)
$58.13B
Revenue Growth
+13.52%
P/S Ratio
4.63
Revenue / Employee
$616.41K
Employees
94,300
Market Cap
200.04B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shell200.18B
BP p.l.c.138.32B
Unilever51.24B
AstraZeneca43.24B
HSBC Holdings43.13B
Rio Tinto Group39.22B
GSK plc32.17B
British American Tobacco p.l.c.25.60B
Revenue Rankings